WHO & Regional Offices [to 05 Mar 2022]

WHO & Regional Offices [to 05 Mar 2022]
https://www.who.int/
News [Selected]
4 March 2022
Departmental news
First-ever malaria vaccine recommendation now published in a position paper and in the WHO guidelines for malaria
[See Perspectives above for detail]

3 March 2022
News release
WHO updates its treatment guidelines to include molnupiravir

3 March 2022
Statement
WHO and MPP welcome NIH’s offer of COVID-19 health technologies to C-TAP

2 March 2022
Departmental news
World leaders and experts call for action to protect the environment from antimicrobial pollution
[See Perspectives above for detail]

2 March 2022
News release
COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide
Scientific brief: Mental health and COVID-19: Early evidence of the pandemic’s impact
1 March 2022
Statement
ACT-Accelerator welcomes Germany’s generous ‘fair share’ commitment
[See Perspectives above for detail]

27 February 2022
Departmental news
Singapore medicines regulator world’s first to achieve highest maturity level in WHO classification
Out of 28 countries formally assessed by WHO, Singapore is the first to have achieved the highest maturity level (ML 4) in WHO’s classification of regulatory authorities for medical products. Achieving ML 4 brings Singapore closer to becoming a WHO listed authority, a new scheme that will be operational later this year and will list the world’s regulators of reference…
Regulation of medical products is extremely important for all health systems and for access to quality vaccines, medicines and other health products. Apart from ensuring the quality, safety and efficacy of medical products, regulatory authorities that function well also perform critical functions such as faster authorization of products and drug safety monitoring after authorization.
WHO’s assessment of regulatory authorities is based on the ‘Global Benchmarking Tool’ – an evaluation tool that checks regulatory functions against a set of more than 260 indicators – covering core regulatory functions such as product authorization, testing of products, market surveillance and the ability to detect adverse events – to establish their level of maturity and functionality. Regulatory authorities that reach maturity levels 3 and 4 will be considered eligible for inclusion among WHO-listed authorities, after additional evaluation of their performance…

27 February 2022
Statement
Dangerously low medical oxygen supplies in Ukraine due to crisis, warn WHO Director-General and WHO Regional Director for Europe

::::::

 

WHO Regional Offices
Selected Press Releases, Announcements
WHO African Region
:: 04 March 2022 Malawi intensifies response after wild poliovirus detected
:: 04 March 2022 Rallying to combat COVID-19 rumours in the Democratic Republic of the Congo
:: 02 March 2022 Obesity rising in Africa, WHO analysis finds

WHO Region of the Americas PAHO
:: A third of pregnant women with COVID-19 unable to access life-saving critical care on time
2 Mar 2022 In the Americas, over 365,000 pregnant women got COVID-19 and more than 3000 died. Ahead of International Women’s Day, PAHO Director urges countries to invest in improving access to vaccines and essential care for women and girls. Washington D.C. 2 March 2022 (PAHO) – A lack of access to timely care and disruptions to prenatal services are to…
:: COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide
2 Mar 2022 Wake-up call to all countries to step up mental health services and support Geneva, 2 March 2022 – In the first year of the COVID-19 pandemic, global prevalence of anxiety and depression increased by a massive 25%, according to a scientific brief released by the World Health Organization (WHO) today. The brief also highlights who has been most…
:: WHO releases new standard to tackle rising threat of hearing loss
Geneva, 2 March 2022 – Over 1 billion people aged 12 to 35 years risk losing their hearing due to prolonged and excessive exposure to loud music and other recreational sounds. This can have devastating consequences for their physical and mental health, education, and employment prospects. Ahead of World Hearing Day 2022, under the theme To…
:: PAHO initiates procedures to elect next Director
1 Mar 2022 Election will take place during the 30th Pan American Sanitary Conference in September 2022, and countries may nominate candidates until May 1, 2022. Washington, D.C., March 1, 2022 (PAHO/WHO) – The process to elect the next Director of the Pan American Sanitary Bureau (PASB) officially began this week with a formal invitation by the President of…

WHO South-East Asia Region SEARO
No new digest content identified

WHO European Region EURO
:: Ukraine’s most vulnerable children in a Kherson home, designed to keep them safe and healthy 05-03-2022
:: Running a hospital while your country is under attack – a story from western Ukraine 01-03-2022

WHO Eastern Mediterranean Region EMRO
:: Nearly 18 000 Yemenis with genetic blood disorders receive lifesaving medications under IsDB-funded WHO programme 1 March 2022
:: WHO delivers SARS-CoV-2 kits for research at Tehran’s Pasteur Institute 28 February 2022
:: Djibouti launches national polio vaccination campaign 27 February 2022

WHO Western Pacific Region
No new digest content identified

 

::::::

WHO Events
https://www.who.int/news-room/events/2
[Selected]
Immunization and vaccines related implementation research advisory committee (IVIR-AC) – March 2022
7 – 11 March 2022

 

::::::

New WHO Publications
https://www.who.int/publications/i
Selected Titles
4 March 2022
Malaria vaccine: WHO position paper – March 2022

3 March 2022
Therapeutics and COVID-19: living guideline

2 March 2022
Mental Health and COVID-19: Early evidence of the pandemic’s impact: Scientific brief, 2 March 2022

2 March 2022
Tuberculosis prevention and care among refugees and other populations in humanitarian settings: an interagency field guide
Overview
Tuberculosis (TB) remains one of the leading infectious diseases causing millions to fall ill and lose their lives annually. Refugees and other populations in humanitarian settings face substantial threats to health and survival, such as poverty, crowded living conditions, undernutrition and poor access to health services – all conditions in which TB transmission thrives.
This guide is a joint effort of the Centers for Disease Control and Prevention (CDC), the UN High Commissioner for Refugees (UNHCR) and the World Health Organization (WHO). It includes new strategic approaches, guidance and innovations for TB prevention and care interventions in humanitarian settings. The guide focuses primarily on managerial/organizational aspects of TB interventions, and provides links to the most updated references for the clinical aspects. We hope this guide can serve as a useful tool in humanitarian settings to alleviate the suffering and deaths caused by this preventable and curable disease, especially for refugees and displaced populations in humanitarian settings.

1 March 2022
Workshop on WHO policy guidance on malaria elimination and the implementation of the intensification plans for reducing malaria burden in the Greater Mekong subregion
Virtual meeting, 22–23 November 2021

28 February 2022
Information for applicants preparing a submission for the 2023 meeting of the WHO Expert Committee on Selection and Use of Essential Medicines

28 February 2022
Continuum of care for noncommunicable disease management during the migration cycle

28 February 2022
Primary health care measurement framework and indicators: monitoring health systems through a primary…

28 February 2022
WHO implementation handbook for national action plans on antimicrobial resistance: guidance for the human…